Arvinas, Inc. (ARVN)
7.21
+0.06
(+0.84%)
USD |
NASDAQ |
Jun 09, 16:00
7.21
0.00 (0.00%)
After-Hours: 18:03
Arvinas SG&A Expense (Quarterly) : 19.10M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Septerna, Inc. | 10.29M |
| Pfizer Inc. | 2.961B |
| Cocrystal Pharma, Inc. | 1.21M |
| CNBX Pharmaceuticals, Inc. | 0.073M |
| GB Sciences, Inc. | -- |